Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

McKesson
McKinsey
Federal Trade Commission
US Department of Justice
Julphar
Colorcon
Boehringer Ingelheim
AstraZeneca
US Army

Generated: April 19, 2018

DrugPatentWatch Database Preview

DOPRAM Drug Profile

« Back to Dashboard

When do Dopram patents expire, and what generic alternatives are available?

Dopram is a drug marketed by West-ward Pharms Int and is included in one NDA.

The generic ingredient in DOPRAM is doxapram hydrochloride. There are four drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the doxapram hydrochloride profile page.
Drug patent expirations by year for DOPRAM
Pharmacology for DOPRAM
Medical Subject Heading (MeSH) Categories for DOPRAM
Synonyms for DOPRAM
(+-)-1-Ethyl-4-(2-morpholinoethyl)-3,3-diphenyl-2-pyrrolidinone monohydrochloride monohydrate
081D530
1-ethyl-4-(2-morpholin-4-ylethyl)-3,3-diphenylpyrrolidin-2-one hydrochloride
1-Ethyl-4-(2-morpholinoethyl)-3,3-diphenyl-2-pyrrolidinone hydrochloride hydrate
1-Ethyl-4-(2-morpholinoethyl)-3,3-diphenyl-2-pyrrolidinone monohydrochloride monohydrate
1-Ethyl-4-(2-morpholinoethyl)-3,3-diphenylpyrrolidin-2-one monohydrochloride
1-ethyl-4-(2-morpholinoethyl)-3,3-diphenylpyrrolidin-2-onemonohydrochloride
113-07-5
113D075
2-Pyrrolidinone, 1-ethyl-4-(2-(4-morpholinyl)ethyl)-3,3-diphenyl-, monohydrochloride
2-Pyrrolidinone, 1-ethyl-4-(2-(4-morpholinyl)ethyl)-3,3-diphenyl-, monohydrochloride, monohydrate
2-Pyrrolidinone, 1-ethyl-4-(2-(4-morpholinyl)ethyl)-3,3-diphenyl-, monohydrochloride, monohydrate, (+-)-
2-Pyrrolidinone, 1-ethyl-4-(2-morpholinoethyl)-3,3-diphenyl-, monohydrochloride
2-Pyrrolidinone, 1-ethyl-4-(2-morpholinoethyl)-3,3-diphenyl-, monohydrochloride, monohydrate
2-Pyrrolidinone,3-diphenyl-, monohydrochloride
3,3-Diphenyl-1-ethyl-4-(2-morpholinoethyl)-2-pyrrolidinone hydrochloride
AC-4694
AC1L21NE
AHR 619
AHR-619
AK-55670
AKOS015906444
AOB5785
API0002485
AS-13336
Bio-0166
C24H30N2O2
C24H30N2O2.HCl
CAS-113-07-5
CCG-101076
CCG-221205
CHEBI:59837
CHEMBL1200876
CPD000469229
CTK8F9367
Doxapram HCL
Doxapram hydrochloride
Doxapram hydrochloride [USAN:JAN]
Doxapram hydrochloride anhydrous
DSSTox_CID_27815
DSSTox_GSID_47837
DSSTox_RID_82579
DTXSID9047837
EINECS 204-022-3
FC1271
H927
J-002892
K-0985
LS-138812
MBGXILHMHYLZJT-UHFFFAOYSA-N
MCULE-1905124271
MFCD00072148
MLS001424142
MolPort-005-973-141
NC00326
NCGC00167459-01
NCGC00167459-02
NSC-170958
NSC170958
SAM001246792
SCHEMBL40645
SMR000469229
Stimulexin
Tox21_112463
Tox21_112463_1

US Patents and Regulatory Information for DOPRAM

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
West-ward Pharms Int DOPRAM doxapram hydrochloride INJECTABLE;INJECTION 014879-001 Approved Prior to Jan 1, 1982 AP RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Farmers Insurance
US Army
AstraZeneca
UBS
Federal Trade Commission
Boehringer Ingelheim
Merck
Chinese Patent Office
Citi

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.